Nanovibronix在关键指标方面向同龄人走去,尽管收入较高,P/E值较低,波动性更大,增长前景较弱。 Nanovibronix trails peers in key metrics despite better earnings and lower P/E, with higher volatility and weaker growth outlook.

Nanovibronix(FEED)是一家医疗设备公司,利用低强度地表声波技术开发CE标记导管产品,尽管收入增加和物价与收入比率降低,但该公司在13个关键指标中的8个跟踪了行业同行。 Nanovibronix (FEED), a medical device company developing CE-marked catheter products using low-intensity surface acoustic wave technology, trails its industry peers on eight of 13 key metrics despite stronger earnings and a lower price-to-earnings ratio. 与外科和牙科仪器部门的竞争者相比,该公司的机构所有权和内幕所有权较低,股票波动性较高,贝塔为2.21,利润率和增长预期值较低。 The company has lower institutional and insider ownership, higher stock volatility with a beta of 2.21, and weaker profitability and growth expectations compared to competitors in the surgical and dental instruments sector.